1. A VLP-Based Vaccine Candidate Protects Mice against Japanese Encephalitis Virus Infection.
- Author
-
Yang, Limin, Xiao, Aibo, Wang, Hu, Zhang, Xiaojuan, Zhang, Yuan, Li, Yunlong, Wei, Yanqiu, Liu, Wenjun, and Chen, Chuangfu
- Subjects
JAPANESE encephalitis viruses ,VIRUS diseases ,PICHIA pastoris ,VIRUS-like particles ,CYTOSKELETAL proteins - Abstract
Japanese encephalitis virus (JEV) is the leading cause of epidemic encephalitis in Asia, and vaccination is the most effective way to prevent JE. Although several licensed vaccines were widely used, there is still a demand for developing safer, cheaper, and more effective JE vaccines. In the current study, a virus-like particle (VLP) vaccine candidate containing the envelope structural protein of JEV expressed by the Pichia pastoris was assembled in vitro. It elicited a robust humoral and cellular immune response in mice model, conferring immunodeficient mice complete protection against lethal doses of JEV challenge. Furthermore, pigs immunized with VLP alone without adjuvant via intramuscular produced high neutralizing antibodies against JEV. Consequently, this study showed a new design of JEV subunit vaccine based on VLP strategy and demonstrated the potential for clinical application. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF